- Home
- HFBL vs VRCA Comparison
HFBL vs VRCA Comparison
Compare HFBL & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- VRCA
- Stock Information
- Founded
- HFBL 1924
- VRCA 2013
- Country
- HFBL United States
- VRCA United States
- Employees
- HFBL N/A
- VRCA N/A
- Industry
- HFBL Savings Institutions
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- HFBL Finance
- VRCA Health Care
- Exchange
- HFBL Nasdaq
- VRCA Nasdaq
- Market Cap
- HFBL 41.7M
- VRCA 43.0M
- IPO Year
- HFBL N/A
- VRCA 2018
- Fundamental
- Price
- HFBL $12.90
- VRCA $0.59
- Analyst Decision
- HFBL
- VRCA Hold
- Analyst Count
- HFBL 0
- VRCA 5
- Target Price
- HFBL N/A
- VRCA $6.00
- AVG Volume (30 Days)
- HFBL 1.9K
- VRCA 268.4K
- Earning Date
- HFBL 07-25-2025
- VRCA 05-13-2025
- Dividend Yield
- HFBL 3.99%
- VRCA N/A
- EPS Growth
- HFBL N/A
- VRCA N/A
- EPS
- HFBL 1.09
- VRCA N/A
- Revenue
- HFBL $20,019,000.00
- VRCA $7,179,000.00
- Revenue This Year
- HFBL N/A
- VRCA $127.85
- Revenue Next Year
- HFBL N/A
- VRCA $105.09
- P/E Ratio
- HFBL $11.80
- VRCA N/A
- Revenue Growth
- HFBL N/A
- VRCA N/A
- 52 Week Low
- HFBL $10.84
- VRCA $0.38
- 52 Week High
- HFBL $14.25
- VRCA $9.36
- Technical
- Relative Strength Index (RSI)
- HFBL 46.36
- VRCA 56.30
- Support Level
- HFBL $12.90
- VRCA $0.49
- Resistance Level
- HFBL $13.84
- VRCA $0.73
- Average True Range (ATR)
- HFBL 0.14
- VRCA 0.07
- MACD
- HFBL -0.02
- VRCA -0.01
- Stochastic Oscillator
- HFBL 0.00
- VRCA 43.71
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.